Broncus Holding Corporation (HKG:2216)
Hong Kong · Delayed Price · Currency is HKD 1.710
+0.010 (0.59%)
Feb 11, 2026, 3:59 PM HKT
Broncus Holding Revenue
Broncus Holding had revenue of $1.65M USD in the half year ending June 30, 2025, a decrease of -68.44%. This brings the company's revenue in the last twelve months to $6.08M, down -30.33% year-over-year. In the year 2024, Broncus Holding had annual revenue of $8.13M, down -20.71%.
Revenue (ttm)
$6.08M
Revenue Growth
-30.33%
P/S Ratio
18.78
Revenue / Employee
$35.55K
Employees
171
Market Cap
896.03M HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.13M | -2.12M | -20.71% |
| Dec 31, 2023 | 10.26M | 842.00K | 8.95% |
| Dec 31, 2022 | 9.41M | -1.48M | -13.57% |
| Dec 31, 2021 | 10.89M | 7.63M | 234.18% |
| Dec 31, 2020 | 3.26M | -4.81M | -59.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.71B |
| Yestar Healthcare Holdings Company | 2.12B |
| Austar Lifesciences | 1.60B |
| Gaush Meditech | 1.58B |
| Vincent Medical Holdings | 869.70M |
| MicroTech Medical (Hangzhou) | 482.95M |
| Venus Medtech (Hangzhou) | 468.17M |
| Shanghai HeartCare Medical Technology Corporation | 367.02M |